AVBP (ArriVent BioPharma) Other Long Term Assets : $0.13 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is ArriVent BioPharma Other Long Term Assets?

ArriVent BioPharma's other long-term assets for the quarter that ended in Dec. 2024 was $0.13 Mil.

ArriVent BioPharma's quarterly other long-term assets increased from Jun. 2024 ($0.12 Mil) to Sep. 2024 ($2.84 Mil) but then stayed the same from Sep. 2024 ($2.84 Mil) to Dec. 2024 ($0.13 Mil).

ArriVent BioPharma's annual other long-term assets increased from Dec. 2022 ($0.07 Mil) to Dec. 2023 ($2.84 Mil) but then declined from Dec. 2023 ($2.84 Mil) to Dec. 2024 ($0.13 Mil).

ArriVent BioPharma Other Long Term Assets Historical Data

The historical data trend for ArriVent BioPharma's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ArriVent BioPharma Other Long Term Assets Chart

ArriVent BioPharma Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Other Long Term Assets

0.09

0.07

2.84

0.13

ArriVent BioPharma Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Long Term Assets	Get a 7-Day Free Trial						2.84	0.11	0.12	2.84	0.13

ArriVent BioPharma Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

ArriVent BioPharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ArriVent BioPharma Inc (NAS:AVBP) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

18 Campus Boulevard, Suite 100, Newtown Square, Philadelphia, PA, USA, 19073

Website

https://www.arrivent.com

ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize the team's deep drug development experience to maximize the potential of the lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody-drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.